In 2011, Mount Sinai embarked on a strategy—across many digital and traditional channels—to ensure a consistent message of growth, strength, and excellence.
It began with the first steps to develop a new logo, and with it, a mission, vision, and values to propel the institution forward as health care in the United States took a revolutionary turn. (more…)
A new chapter is unfolding at the Mount Sinai Health System, one that defines Mount Sinai’s leadership in providing seamless patient care—for you, for life—throughout New York City. It also showcases Mount Sinai’s significant contributions to research and medical education, and highlights innovative collaborations around the world that advance health care. For the first time since the Health System was formed in 2013, this story is being shared with the public in an advertising campaign that was launched in the Sunday, July 19, issue of The New York Times Magazine. (more…)
A unique method of increasing the number of cord blood stem cells used to treat patients with blood cancers and blood disorders, such as sickle cell anemia, is being readied for clinical trials at the Icahn School of Medicine at Mount Sinai, with an $8.8 million grant from the New York State Stem Cell Science Program (NYSTEM).
The stem cells—also known as hematopoietic stem cells—are derived from the vein of the umbilical cord and help renew and replenish blood cells. They represent the only potential therapy for blood cancer patients who do not respond to chemotherapy. The new method is necessary to compensate for the limited number of stem cells that are typically found in blood cord collections and the fact that using stem cells from two or more blood cord collections is generally not a viable option because the blood cells are not identical. (more…)
Sean P. Pinney, MD, was recently named the first Director of Heart Failure and Transplantation for the Mount Sinai Health System. He will also continue to serve as Director of Advanced Heart Failure and Transplantation at The Mount Sinai Hospital and Associate Professor of Medicine (Cardiology) at Icahn School of Medicine at Mount Sinai, where he has led a number of clinical trials in heart failure, cardiac transplantation, and mechanical circulatory support. (more…)
Mount Sinai scientists and clinicians are making notable advances in the study and treatment of heart failure, a common condition that occurs when the heart becomes too weak to pump and circulate enough blood through the body. Diseases that damage the heart—such as coronary artery disease, high blood pressure, and diabetes—can lead to heart failure, which develops over time as the heart’s pumping action grows weaker. It impacts an estimated 5 million adults and children in this country. (more…)
The Mount Sinai Transplant Living Center, which provides convenient and affordable overnight accommodations to patients and their families receiving care at the Recanati/Miller Transplantation Institute (RMTI), has undergone a full renovation, featuring new kitchens, bathrooms, and furniture.
The renovation was a generous gift from benefactors Ken and Meryl Sherman who were looking to give back to RMTI on the fourteenth anniversary of Mrs. Sherman’s successful kidney transplant, for which Mr. Sherman was the donor. (more…)